Recent News

• 08.08.2025 - Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance
• 08.06.2025 - Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
• 04.30.2025 - Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance
• 04.28.2025 - Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30
• 04.22.2025 - Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
• 04.03.2025 - Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries
• 03.07.2025 - Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR

Recent Filings

• 08.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.08.2025 - EX-99.1 EX-99.1
• 08.08.2025 - 8-K Current report
• 07.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.02.2025 - 8-K Current report
• 05.20.2025 - SD Specialized disclosure report
• 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.30.2025 - 8-K Current report
• 04.30.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]